related machine failures since neither medical professionals nor buyers have all of the data needed to make adequate judgments of product or service high quality and authorized tort treatments are sluggish, inefficient, and intensely costly. The alterations on the CGMP regulation will require manufacturers to extend [Web site 52644] their high-qual